Skip to main content
Emerging therapies

Emerging therapies

Focused ultrasound: a potential treatment for type 2 diabetes?

12 May 2022
GE researchers
GE researchers (left to right): Victoria Cotero, a senior scientist in biosciences, senior electrical engineer Jeffrey Ashe and senior biomedical engineer Christopher Puleo, with a prototype of the ultrasound modulation device at GE’s research campus in Niskayuna, NY. (Courtesy: General Electric)
Ultrasound neuromodulation can prevent the onset of hyperglycaemia or reverse type 2 diabetes in lab

You’ve reached the limit of what you can view on Physics World without registering

If you already have an account on Physics World, then please sign in to continue reading

If you do not yet have an account, please register so you can

  • Access more than 20 years of online content
  • Choose which e-mail newsletters you would like to receive
Copyright © 2024 by IOP Publishing Ltd and individual contributors